Literature DB >> 22840839

Maintaining poise: commensal microbiota calibrate interferon responses.

Jeremy P McAleer1, Jay K Kolls.   

Abstract

The mechanisms of how commensal bacteria impact systemic immunity are unclear. In this issue of Immunity, Abt et al. (2012) and Ganal et al. (2012) demonstrate that microbiota poise macrophages for induction of the type I interferon pathway after virus infection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Year:  2012        PMID： 22840839     DOI： 10.1016/j.immuni.2012.07.001

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  18 in total

1.  Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Audrey Lasri; Ning Li; Daniel P Beiting; Amy C Durham; Ting Yang; Eli Pikarsky; Christopher J Lengner; F Brad Johnson; Yinon Ben-Neriah; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2016-01-25       Impact factor: 4.272

2.  MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype.

Authors:  Emilie Plantamura; Amiran Dzutsev; Mathias Chamaillard; Sophia Djebali; Lyvia Moudombi; Lilia Boucinha; Morgan Grau; Claire Macari; David Bauché; Oana Dumitrescu; Jean-Philippe Rasigade; Saskia Lippens; Michelina Plateroti; Elsa Kress; Annabelle Cesaro; Clovis Bondu; Ulrike Rothermel; Mathias Heikenwälder; Gerard Lina; Azzak Bentaher-Belaaouaj; Julien C Marie; Christophe Caux; Giorgio Trinchieri; Jacqueline Marvel; Marie-Cecile Michallet
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-24       Impact factor: 11.205

3.  Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.

Authors:  Tiha M Long; Shahista Nisa; Michael S Donnenberg; Bret A Hassel
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

4.  Impact of prior antibiotic use on the efficacy of nivolumab for non-small cell lung cancer.

Authors:  Taiki Hakozaki; Yusuke Okuma; Miwako Omori; Yukio Hosomi
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

5.  Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

Authors:  Noriho Iida; Amiran Dzutsev; C Andrew Stewart; Loretta Smith; Nicolas Bouladoux; Rebecca A Weingarten; Daniel A Molina; Rosalba Salcedo; Timothy Back; Sarah Cramer; Ren-Ming Dai; Hiu Kiu; Marco Cardone; Shruti Naik; Anil K Patri; Ena Wang; Francesco M Marincola; Karen M Frank; Yasmine Belkaid; Giorgio Trinchieri; Romina S Goldszmid
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

6.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

Authors:  Ayelet Sivan; Leticia Corrales; Nathaniel Hubert; Jason B Williams; Keston Aquino-Michaels; Zachary M Earley; Franco W Benyamin; Yuk Man Lei; Bana Jabri; Maria-Luisa Alegre; Eugene B Chang; Thomas F Gajewski
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

Review 7.  A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints.

Authors:  Yongshu Li; Fangfei Li; Feng Jiang; Xiaoqing Lv; Rongjiang Zhang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-07-18       Impact factor: 5.923

Review 8.  Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology.

Authors:  Johanna Pott; Silvia Stockinger
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

Review 9.  The Protective Role of Type I Interferons in the Gastrointestinal Tract.

Authors:  Kevin P Kotredes; Brianna Thomas; Ana M Gamero
Journal:  Front Immunol       Date:  2017-04-06       Impact factor: 7.561

10.  Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge.

Authors:  Markus J Lehtinen; Ashley A Hibberd; Sofia Männikkö; Nicolas Yeung; Tommi Kauko; Sofia Forssten; Liisa Lehtoranta; Sampo J Lahtinen; Buffy Stahl; Anna Lyra; Ronald B Turner
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.